Explore the advantages, limitations, and best applications of dPCR, qPCR, and RT-qPCR in preclinical and clinical development.

This webinar examines the strengths and challenges of today's leading PCR technologies and their role in supporting bioanalytical testing for vaccines, gene therapies, cell therapies, and other biotherapeutics. Learn how to select the appropriate PCR platform based on study objectives, regulatory requirements, and analytical performance.

In this webinar, you'll learn:

• The differences between dPCR, qPCR, and RT-qPCR, and when to use each technology
• The advantages and limitations of each platform for bioanalytical applications
• Best practices for PCR assay development, validation, and regulatory compliance
• How PCR technologies support biodistribution, vector shedding, gene expression, CAR T-cell, and oncolytic virus studies

As advanced therapeutics continue to evolve, selecting the right PCR platform is essential for generating accurate, reliable data. Discover how dPCR, qPCR, and RT-qPCR can support robust bioanalysis and successful preclinical and clinical development.